All compounds
Other research compoundsClinical-stage compound

NSI-189

An investigational small molecule studied in early human trials for neuropsychiatric indications but not approved as a medicine.

Reference reviewed 5 September 2026 · No dosing or protocol information
01

What the name refers to

An investigational small molecule studied in early human trials for neuropsychiatric indications but not approved as a medicine.

02

Evidence and regulatory context

Human clinical research exists, but this entry is not a broadly authorised consumer medicine. Trial results apply to the studied formulation, population and endpoints—not automatically to products sold online.

03

Reading product records

These names do not form one pharmacological class. Each record must be read compound by compound, with special attention to the difference between an authorised medicine, an investigational candidate, a regional product and an online research listing.

04

Primary research links

Use current regulator and study records rather than treating a catalogue description as medical evidence.